- Home
- CGON vs TUYA Comparison
CGON vs TUYA Comparison
Compare CGON & TUYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGON
- TUYA
- Stock Information
- Founded
- CGON 2010
- TUYA 2014
- Country
- CGON United States
- TUYA China
- Employees
- CGON N/A
- TUYA N/A
- Industry
- CGON
- TUYA Computer Software: Prepackaged Software
- Sector
- CGON
- TUYA Technology
- Exchange
- CGON NYSE
- TUYA Nasdaq
- Market Cap
- CGON 1.3B
- TUYA 1.5B
- IPO Year
- CGON 2024
- TUYA 2021
- Fundamental
- Price
- CGON $20.64
- TUYA $1.95
- Analyst Decision
- CGON Strong Buy
- TUYA
- Analyst Count
- CGON 10
- TUYA 0
- Target Price
- CGON $65.11
- TUYA N/A
- AVG Volume (30 Days)
- CGON 1.3M
- TUYA 2.5M
- Earning Date
- CGON 05-08-2025
- TUYA 05-19-2025
- Dividend Yield
- CGON N/A
- TUYA 5.61%
- EPS Growth
- CGON N/A
- TUYA N/A
- EPS
- CGON N/A
- TUYA 0.01
- Revenue
- CGON $1,139,000.00
- TUYA $298,617,000.00
- Revenue This Year
- CGON N/A
- TUYA $22.34
- Revenue Next Year
- CGON $16,237.24
- TUYA $18.11
- P/E Ratio
- CGON N/A
- TUYA $223.93
- Revenue Growth
- CGON 461.08
- TUYA 29.84
- 52 Week Low
- CGON $14.80
- TUYA $1.28
- 52 Week High
- CGON $46.99
- TUYA $4.63
- Technical
- Relative Strength Index (RSI)
- CGON 43.38
- TUYA 27.45
- Support Level
- CGON $19.47
- TUYA $1.93
- Resistance Level
- CGON $20.63
- TUYA $2.13
- Average True Range (ATR)
- CGON 2.07
- TUYA 0.19
- MACD
- CGON 0.20
- TUYA -0.07
- Stochastic Oscillator
- CGON 48.59
- TUYA 3.39
About CGON CG ONCOLOGY INC
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
About TUYA Tuya Inc. each representing one
Tuya Inc is an IoT cloud development platform with a mission to build an IoT developer ecosystem and enable everything to be smart. The Company has pioneered a purpose-built IoT cloud development platform that delivers a full suite of offerings, including platform-as-a-service (PaaS) and Software-as-a-service (SaaS), to businesses and developers. Through its IoT cloud development platform, It has enabled developers to activate a vibrant IoT ecosystem of brands, OEMs, partners, and end users to engage and communicate through a broad range of smart devices. The company's revenue is derived from the PRC.